emergentec biodevelopment GmbH - Company Review
emergentec biodevelopment GmbH - Company ReviewSummary
emergentec biodevelopment GmbH (emergentec biodevelopment) is a medical technology company that provides decision support solutions for drug target, biomarker and drug development. The company offers clinical stage testing, preclinical development, and translation research. It discovers molecular content to develop biomarkers and targets into diagnostics and therapy products. emergentec biodevelopment’s software platform e.valuation embeds fully integrated knowledge aggregation workflows for executing molecular asset evaluation. The company involves in planning and managing various projects from industrial collaborations, research and development programs, and services projects. It serves to pharmaceutical and biotech companies. emergentec biodevelopment is headquartered in Vienna, Austria.
This comprehensive company report of emergentec biodevelopment GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.